SRSF3 and hepatocellular carcinoma: In contrast, we found seven out of nine mice with liver Srsf3 KO, but only one of 15 mice bearing WT Srsf3 with DEN injection, developed pathological hepatocellular carcinoma at the 6th month of mice age (Figure 1C).